Sellas Life Sciences Group

(NASDAQ) SLS

Current Price$5.15

Market Cap$885.34M

Since IPO (2018)-99%

5 Year-37%

1 Year+204%

1 Month+17%

Sellas Life Sciences Group Financials at a Glance

Market Cap

$885.34M

Revenue (TTM)

$0.00

Net Income (TTM)

$26.86M

EPS (TTM)

$-0.25

P/E Ratio

-20.05

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$5.15

Volume

778,354.056

Open

$4.91

Price

$5.15

Volume

778,354.056

Open

$4.91

Previous Close

$4.93

Daily Range

$4.90 - $5.14

52-Week Range

$1.36 - $6.14

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$5.15

Volume

778,354.056

Open

$4.91

Previous Close

$4.93

Daily Range

$4.90 - $5.14

52-Week Range

$1.36 - $6.14

SLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sellas Life Sciences Group

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Angelos M. Stergiou, MD

Website

www.sellaslifesciences.com

Headquarters

New York City, NY 10036, US

SLS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-67%

Return on Capital

-40%

Return on Assets

-34%

Earnings Yield

-4.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$885.34M

Shares Outstanding

179.58M

Volume

778.35K

Avg. Volume

6.23M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$28.27M

EBITDA

$28.27M

Operating Cash Flow

$28.39M

Capital Expenditure

$0.00

Free Cash Flow

$28.39M

Cash & ST Invst.

$71.89M

Total Debt

$1.00M

Sellas Life Sciences Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$885.34M

N/A

Market Cap/Employee

$59.02M

N/A

Employees

N/A

Net Income

$7.66M

-13.7%

EBITDA

$8.26M

+49.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$70.89M

+450.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$457.00K

+0.0%

Short Term Debt

$544.00K

+0.0%

Return on Assets

-34.29%

N/A

Return on Invested Capital

-39.64%

N/A

Free Cash Flow

$4.92M

+31.2%

Operating Cash Flow

$4.92M

+31.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNFTGenfit S.A.

GNFTGenfit S.A.$8.95+4.07%

PRLDPrelude Therapeutics Incorporated

PRLDPrelude Therapeutics Incorporated$4.75+1.06%

CCCCC4 Therapeutics, Inc.

CCCCC4 Therapeutics, Inc.$2.94+0.51%

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.67+0.37%

TARAProtara Therapeutics, Inc.

TARAProtara Therapeutics, Inc.$5.49+3.20%

IVVDInvivyd, Inc.

IVVDInvivyd, Inc.$1.54+1.35%

MDWDMediWound Ltd.

MDWDMediWound Ltd.$16.78+0.90%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$9.30+3.02%

NOKNokia

NOKNokia$13.44+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.22+0.01%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.12-0.09%

CLNNClene

CLNNClene$6.70+0.09%

GMEGameStop

GMEGameStop$25.36-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$49.93-0.01%

Questions About SLS

What is the current price of Sellas Life Sciences Group?

Sellas Life Sciences Group is trading at $5.12 per share.

What is the 52-week range for Sellas Life Sciences Group?

Over the past 52 weeks, Sellas Life Sciences Group has traded between $1.36 and $6.14.

How much debt does Sellas Life Sciences Group have?

As of the most recent reporting period, Sellas Life Sciences Group reported total debt of $1.00M.

How much cash does Sellas Life Sciences Group have on hand?

Sellas Life Sciences Group reported $71.89M in cash and cash equivalents in its most recent financial results.

What is Sellas Life Sciences Group’s dividend yield?

Sellas Life Sciences Group does not currently have a dividend yield.

Sellas Life Sciences Group

Sellas Life Sciences Group Financials at a Glance

SLS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sellas Life Sciences Group

SLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sellas Life Sciences Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SLS

What is the current price of Sellas Life Sciences Group?

What is the 52-week range for Sellas Life Sciences Group?

How much debt does Sellas Life Sciences Group have?

How much cash does Sellas Life Sciences Group have on hand?

What is Sellas Life Sciences Group’s dividend yield?

Premium Investing Services